Acute concomitant glucose‐dependent insulinotropic polypeptide receptor antagonism during glucagon‐like peptide 1 receptor agonism does not affect appetite, resting energy expenditure or food intake in patients with type 2 diabetes and overweight/obesity. Issue 9 (20th June 2022)

• Record Type: Journal Article
• Authors: Stensen, Signe; Krogh, Liva L.; Sparre‐Ulrich, Alexander H.; Dela, Flemming; Hartmann, Bolette; Vilsbøll, Tina; Holst, Jens J.; Rosenkilde, Mette M.; Christensen, Mikkel B.; Gasbjerg, Lærke S.; Knop, Filip K.
• Is Part Of: Diabetes, obesity & metabolism. Volume 24:Issue 9(2022)
• Page Start: 1882
• Page End: 1887
• Publication Date: 2022-06-20
• Subjects: GIP -- GIP receptor antagonist -- GLP‐1 -- incretin hormones -- incretins -- obesity -- type 2 diabetes; Diabetes -- Periodicals; Obesity -- Periodicals; Metabolism -- Disorders -- Periodicals; Clinical pharmacology -- Periodicals; 616.462
• DOI: 10.1111/dom.14736
• Languages: English
• ISSNs: 1462-8902